AVANOS MEDICAL, INC. Files 8-K Report

Ticker: AVNS · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1606498

Avanos Medical, INC. 8-K Filing Summary
FieldDetail
CompanyAvanos Medical, INC. (AVNS)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

Related Tickers: AVNS

TL;DR

AVNS filed an 8-K, standard reporting stuff.

AI Summary

On January 13, 2025, AVANOS MEDICAL, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard reporting activity for the company.

Why It Matters

This filing signifies that Avanos Medical, Inc. is adhering to its reporting obligations with the SEC, providing updates on its financial statements and exhibits.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report for disclosure and exhibits, not indicating any immediate material changes or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by AVANOS MEDICAL, INC.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on January 13, 2025.

What is the SEC file number for AVANOS MEDICAL, INC.?

The SEC file number for AVANOS MEDICAL, INC. is 001-36440.

Where are AVANOS MEDICAL, INC.'s principal executive offices located?

AVANOS MEDICAL, INC.'s principal executive offices are located at 5405 Windward Parkway Suite 100 South Alpharetta, Georgia 30004.

What is the I.R.S. Employer Identification Number for AVANOS MEDICAL, INC.?

The I.R.S. Employer Identification Number for AVANOS MEDICAL, INC. is 46-4987888.

Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-13 11:01:38

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On January 13, 2025, Avanos Medical, Inc. will present and discuss during the 43 rd Annual JP Morgan Healthcare Conference the slide presentation furnished herewith as Exhibit 99.1 to this Current Report and incorporated herein by reference. The information furnished pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 99.1 Presentation dated January 13, 2025 delivered to JP Morgan Healthcare Conference 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVANOS MEDICAL, INC. Date: January 13, 2025 By: /s/ Mojirade James Mojirade James Senior Vice President and General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing